Recall Register

Drug recall: Drospirenone and Ethinyl Estradiol Tablets, USP, 3 mg/0.02 mg, packaged into a carton containing 3 blister cards each…

Class I FDA enforcement event 83408. Recall start date: . Status in the FDA record: Terminated. Termination date: .

Reason for recall, in the words of FDA

Failed dissolution specifications : failed results at the 3-month stability time point.

Class I, in the words of FDA

a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death

Jubilant Cadista Pharmaceuticals, Inc. started this drug recall on 9 Jul 2019. The firm address in the FDA record is in Salisbury, MD. FDA put the recall in Class I. FDA event 83408 has 1 product record. The first FDA enforcement report date is 7 Aug 2019. The record gives the status Terminated, with the termination date 7 May 2021.

It is important to note that most of the time recall classifications are determined after the recalling firm provides all of the information needed to determine the risk posed to public health. The classification and posting in the FDA Enforcement Report should not be seen as an expansion or change to a firm’s voluntary public warning.

FDA publishes these words. Source: FDA, Enforcement Reports, Important Note, read on . openFDA export of .

Distribution

In the words of FDA.

USA Nationwide

Recalling firm

Jubilant Cadista Pharmaceuticals, Inc., Salisbury, MD.

Recalling firm: The firm that the FDA record names for a recall.

FDA records how the recall started: Voluntary: Firm initiated.

Products

1 product record in the event.

FDA event 83408: product records
Recall numberProductQuantityClassStatusReport date
D-1837-2019Drospirenone and Ethinyl Estradiol Tablets, USP, 3 mg/0.02 mg, packaged into a carton containing 3 blister cards each blister card contains 28-film coated, biconvex tablets, Rx Only, Manufactured by: Cyndea Pharma, S.L., Olvega (Soria), 42110 Spain, Distributed by: Jubilant Cadista Pharmaceuticals, Inc., Salisbury,…11,412 cartons/34,236 blister cards/28 tablets each cardClass ITerminated7 Aug 2019

openFDA, about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports. Source: openFDA, Drug Recall Enforcement Reports, Disclaimer.

Enforcement report: The FDA publication that lists recalls. It has one record for each product of a recall.

Enforcement event: All the product records that have one FDA event number. This site shows one event on one page.

Class I: The highest of the three FDA recall classes.

The event in context

Drug events that started in 2019
362
Share of these events in Class I
10%
Product records in this event
1Median of the firm: 1
Events of the firm on the register
25

Other events of the firm

Other FDA enforcement events of Jubilant Cadista Pharmaceuticals, Inc.
InitiatedProduct (first record)TypeClassRecords
27 Dec 2022Prochlorperazine Maleate Tablets, USP 5mg, 100 tablets, RX Only, Jubilant Cadista Pharmaceuticals, Inc., Salisbury, MaryDrugClass III1
18 Jul 2022Irbesartan Tablets, USP, 150mg, 90- count bottles, Rx only, Manufactured by: Jubilant Generics Ltd. Roorkee- 247661, IndDrugClass II2
1 Apr 2022Methylprednisolone Tablets, USP 4mg, 100-count bottle, Rx Only, Manufactured by: Jubliant Cadista Pharmaceuticals Inc. SDrugClass III1
8 Mar 2022Meclizine Hydrochloride Tablets USP, 12.5 mg, packaged in a case of 24 bottles (100-count bottle), Rx only, ManufacturedDrugClass I1
20 Aug 2021Donepezil HCL Tablets, USP, 5 mg, 90-count bottle, Rx only, Manufactured by: Jubilant Generics Ltd. India, Marketed by: DrugClass III1
1 Apr 2021Itraconazole Capsules, 100 mg, 30-count bottles, Rx only, Manufactured by: Jubilant Generics Ltd., Roorkee - 247661, IndDrugClass II1
19 Feb 2021Methylprednisolone Tablets USP, 4 MG, packaged in a 21-count blister pack, Rx only, Jubilant Cadista Pharmaceuticals, InDrugClass III1
6 Nov 2020clomiPRAMINE Hydrochloride Capsules USP, 50 mg, 30-count bottle, Rx Only, Manufactured by: Jubilant Cadista PharmaceuticDrugClass II1
26 Oct 2020Olanzapine Orally Disintegrating Tablets, 5 mg, 30 count (3x10 unit dose) blister pack, Rx only, Manufactured by: JubilaDrugClass III1
26 May 2020Lamotrigine Tablets, USP, 150 mg, 20,000-count bulk container, Manufactured by: Jubilant Cadista Pharmaceuticals Inc., SDrugClass III1

Jubilant Cadista Pharmaceuticals, Inc.: all 25 events

Official channels

Cite this page

Recall Register. FDA enforcement event 83408. https://recallregister.com/fda/i/83408/. Source: openFDA enforcement reports. Data through .

Sources

Source
openFDA drug enforcement reports
Licence
CC0 1.0
Export date
28 Sep 2026
Newest FDA report date on the register
23 Sep 2026

FDA has one record for each product. This site puts the records with the same event number on one page. The class of the event is the highest class of its records. How the register is made. Report an error.

Questions

Where was the product distributed?
The FDA record gives this distribution: USA Nationwide
What quantity of product is in FDA event 83408?
The FDA record gives this quantity: 11,412 cartons/34,236 blister cards/28 tablets each card
How did the recall start?
The FDA record says: Voluntary: Firm initiated
How many drug recalls of 2019 have the same class?
10% of the 362 drug events that started in 2019 are in Class I.